Skip to main navigation
Investor Relations
Overview
Stock Information
Stock Quote & Chart
News & Events
News Releases
Events
Presentations
Financial Information
SEC Filings
Governance
Governance Overview
Committee Composition
Board of Directors
Leadership
Resources
Investor FAQs
Email Alerts
Contact IR
Event Details
First Patient Dosed in Pivotal Phase 3 NEAT Clinical Trial
June 26, 2024
Webcast
Shareholder Tools
Print Page
RSS
E-mail Alerts
Search
Facebook
Twitter
LinkedIn
Google+
